INSYS Therapeutics, Inc. filed an amended plan of liquidation with related disclosure statement in the US Bankruptcy Court on November 14, 2019. As per the amended plan filed, Administrative Expense Claims are of $2.8 million and Priority Tax Claims are of $0.7 million. A new claim class, Convenience Class Claims, has been added to the plan and shall receive available cash. Other Priority Claims are of $0.1 million. Insurance Related Claim shall receive from Insys Liquidation Trust, share of estate distributable value attributable to Insurance Related Claim calculated in accordance with the plan distribution formula and in accordance with the Third Party Payor Class Claim Procedures and the Insurance Ratepayer Procedures, as applicable. Hospital Claims and NAS Monitoring Claims shall receive from Insys Liquidation Trust, share of estate distributable value attributable to the claim calculated in accordance with the Hospital Class Procedures and The NAS Monitoring Class Procedures, as applicable. DOJ Claims of $273 million shall receive from Insys Liquidation Trust all estate distributable value attributable to DOJ Claims calculated in accordance with the plan distribution formula. SMT Group Claims shall receive from Insys Liquidation Trust and the Victims Restitution Trust it’s pro rata share of (i) estate distributable value attributable to SMT Group Claims in accordance with plan distribution formula, (ii) 10% interest in any Products Liability Insurance Proceeds, and (iii) 100% interest in any excess products liability insurance proceeds. Personal Injury Claims shall receive from the Victims Restitution Trust, its pro rata share of 90% of any products liability insurance proceeds. 510(a) and 510(b) subordinated claims has been renamed as 510(a)/(b) Subordinated Claims. There are no changes in the treatment of any other claim class.